1. SOX2 in development and cancer biology
   Daniel Novak et al, 2020, Seminars in Cancer Biology CrossRef
2. SOX2 and squamous cancers
   Linsey Porter et al, 2020, Seminars in Cancer Biology CrossRef
3. SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low- and high-grade CIN
   Jobran M. Moshi et al, 2022, Histochemistry and Cell Biology CrossRef
4. Cell Therapy with Human Reprogrammed CD8+ T-Cells Has Antimetastatic Effects on Lewis Lung Carcinoma in C57BL/6 Mice
   Evgenii G. Skurikhin et al, 2022, International Journal of Molecular Sciences CrossRef
5. The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies
   Samaneh Mollazadeh et al, 2023, Heliyon CrossRef
6. Conducting polymer composite-based biosensing materials for the diagnosis of lung cancer: A review
   Heru Agung Saputra et al, 2023, International Journal of Biological Macromolecules CrossRef
7. The role of SOX family members in solid tumours and metastasis
   Daniela Grimm et al, 2020, Seminars in Cancer Biology CrossRef
8. p21-activated kinase 2 binds to transcription factor SOX2 and up-regulates DEK to promote the progression of lung squamous cell carcinoma
   Shiguang Xie et al, 2022, Laboratory Investigation CrossRef
9. SOX2 promoter hypermethylation in non-smoking Taiwanese adults residing in air pollution areas
   Disline Manli Tantoh et al, 2019, Clinical Epigenetics CrossRef
10. SOX2 como posible biomarcador pronóstico y diana molecular en el cáncer de pulmón: metaanálisis
    K. Zang et al, 2022, Revista Clínica Española CrossRef
11. HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer
    Abla Abou-Zeid et al, 2023, BMC Cancer CrossRef
12. Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
    Daniel Pedregal-Mallo et al, 2020, Cancers CrossRef
13. The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells
    Malgorzata Kucinska et al, 2024, Biomedicine & Pharmacotherapy CrossRef
14. Blood-Based SOX2-Promoter Methylation in Relation to Exercise and PM2.5 Exposure among Taiwanese Adults
    Chun-Lang Su et al, 2020, Cancers CrossRef
15. SOX2 como posible biomarcador pronóstico y diana molecular en el cáncer de pulmón: metaanálisis
    K. Zang et al, 2022, Revista Clínica Española (English Edition) CrossRef
16. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
    Kenly Wuputra et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef